← Back to Patent Explorer
US4594349A Expired / Lapsed US ⏱️ 0.0 years remaining

Hyperuretic agents

Assignee: Individual
•
Filing: 1982-01-04
•
Granted: 1986-06-10
•
Expires: 2002-01-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Hyperuretic agents of the formula: ##STR1## wherein Y is O or NH; R is OH; NHCONR 4 R 5 ; or N═C(NR 4 R 5 ) 2 ; R 1 and R 2 are hydrogen, amino, or mono- or disubstituted amino, provided that R 1 and R 2 may not both be amino or substituted amino; and R 3 is hydrogen or halo; enhance renal excretion of urea, thereby lowering plasma urea concentration, and are therefore useful for treating hypertension, eclampsia, uremia, and similar disorders.

Inventors

  • 👤 Karl H. Beyer, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 17:15
CPC Classifications
C; C07; C07D; C07D241/00; C07D241/02; C07D241/10; C07D241/14; C07D241/24; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/54; A61P; A61P7/00; A61P7/10; A61P9/00; A61P9/12; C07D241/26

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 167 words
A method of treating a hyperuremic condition comprising administering to a host in need of such treatment a therapeutically effective amount of a compound of the formula: ##STR5## wherein Y is O or NH, R is OH; NHCONR 4 R 5 ; or N═C(NR 4 R 5 ) 2 ; where R 4 and R 5 are each independently selected from the group consisting of hyrogen; C 1-10 alkyl, straight or branched chain; aryl C 1-4 alkyl; mono- or disubstituted aryl C 1-4 alkyl where the substituents are fluoro, chloro, bromo, iodo, or C 1-10 alkyl, straight or branched chain; R 1 and R 2 are each independently selected from the group consisting of hydrogen, amino, and mono- or disubstituted amino where the substituents are C 1-10 alkyl, straight or branched chain, or C 3-8 cycloalkyl; provided that R 1 and R 2 may not both be amino or substituted amino; and R 3 is hydrogen; fluoro; chloro; bromo; or iodo; and a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim 167 words
A method of treating a hyperuremic condition comprising administering to a host in need of such treatment a therapeutically effective amount of a compound of the formula: ##STR5## wherein Y is O or NH, R is OH; NHCONR 4 R 5 ; or N═C(NR 4 R 5 ) 2 ; where R 4 and R 5 are each independently selected from the group consisting of hyrogen; C 1-10 alkyl, straight or branched chain; aryl C 1-4 alkyl; mono- or disubstituted aryl C 1-4 alkyl where the substituents are fluoro, chloro, bromo, iodo, or C 1-10 alkyl, straight or branched chain; R 1 and R 2 are each independently selected from the group consisting of hydrogen, amino, and mono- or disubstituted amino where the substituents are C 1-10 alkyl, straight or branched chain, or C 3-8 cycloalkyl; provided that R 1 and R 2 may not both be amino or substituted amino; and R 3 is hydrogen; fluoro; chloro; bromo; or iodo; and a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 36 words
A method according to claim 1 wherein in Formula I Y is O or NH; one of R 1 and R 2 is hydrogen or amino and the other is hydrogen; and R 3 is hydrogen.
Claim 4
Dependent Claim 14 words
A method according to claim 1 wherein the compound of Formula I is pyrazinoylguanidine.
Claim 5
Dependent Claim 14 words
A method according to claim 1 wherein the comound of Formula I is 3-aminopyrazinoylguanidine.
Claim 6
Dependent Claim 12 words
A method according to claim 1 wherein the hyperuremic condition is uremia.

References Cited (Backward Citations)

US3345372A Cited
US3539569A Cited
US3544571A Cited
US3948895A Cited
US4085211A Cited
US4087526A Cited
US4196292A Cited
US4246406A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-06-09 1989-12-09 1990-06-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-06-09 1993-12-09 1994-06-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-06-09 1997-12-09 1998-06-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag